Steinling M, Mazingue A, Rousseaux M, Destee A, Blanc D, Warot P, Vergnes R
Service Central de Médecine Nucléaire, Centre Hospitalier Universitaire de Lille, Hôpital B. Lille.
Acta Neurol Belg. 1987 May-Jul;87(3):113-24.
123Iodo-Amphetamine (IAMP) brain distribution was studied with a specially dedicated multilevel tomographic system in 30 patients with vascular ischemic (18) or hemorrhagic (12) disorders. Results were compared with clinical data, CT scan and rCBF measurement obtained by the 133Xe continuous inhalation method. Abnormalities with IAMP were found in 27 cases, in good agreement with the results obtained by the Xenon inhalation technique in 21 studies from the 22 where that method was possible. For 80% cases there was also a good agreement between the results obtained by the IAMP and CT scan: one case normal, and 23 observations with abnormalities. This is true for the localization of lesions, but IAMP appears able to shown remote abnormalities, i.e. crossed cerebellar diaschisis or functional deactivation, in the absence of CT scan lesions in the corresponding areas. This is of particular interest in the protracted regressive ischemic neurologic disorders (PRIND): CT scan were normal in all five observations but IAMP showed abnormalities in four cases. IAMP is however very expensive, so it has to be used only when 133Xe inhalation is technically impossible.
采用专门的多层断层扫描系统对30例血管性缺血性(18例)或出血性(12例)疾病患者的123碘安非他明(IAMP)脑分布进行了研究。将结果与临床数据、CT扫描以及通过133氙连续吸入法获得的局部脑血流量测量结果进行了比较。27例患者发现IAMP异常,在22项可行该方法的研究中,有21项研究其结果与氙吸入技术获得的结果高度一致。80%的病例中,IAMP与CT扫描结果也高度一致:1例正常,23例观察到异常。在病变定位方面确实如此,但IAMP似乎能够显示出远处的异常,即在相应区域CT扫描无病变的情况下出现交叉性小脑失联络或功能失活。这在迁延性退行性缺血性神经疾病(PRIND)中尤为重要:所有5例观察中CT扫描均正常,但IAMP在4例中显示异常。然而,IAMP非常昂贵,因此只有在技术上无法进行133氙吸入时才使用。